Text Module
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer questions focused on the optimizing BTK inhibitor therapy for previously untreated patients with CLL considering presentation characteristics and drug pharmacology.
Content based on an online CME program supported by an educational grant from AstraZeneca.Link to full program, including associated downloadable slidesets: https://www.clinicaloptions.com/oncology/programs/cll-horizons
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Expert case-based text module on managing toxicities with BCL-2 and PI3K inhibitors in CLL, from Clinical Care Options (CCO)
Nichole Fisher, RN, BSN
Nicole Lamanna, MD
Anthony Perissinotti, PharmD, BCOP
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: May 19, 2022
Expired:
May 18, 2023
Experts review key data for multiple myeloma at the 2021 hematology annual meeting, from Clinical Care Options (CCO)
Shaji K. Kumar, MD
Sagar Lonial, MD
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: May 12, 2022
Expired:
May 11, 2023
Clinical Care Options (CCO): Expert review of key data in MDS and MPN from the 2021 ASH annual meeting
Amy E. DeZern, MD, MHS
Srdan Verstovsek, MD, PhD
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: May 11, 2022
Expired:
May 10, 2023
Clinical Care Options (CCO): Experts John M. Burke, MD, and Peter Martin, MD, review key data in lymphomas and CLL presented at the 2021 American Society of Hematology Annual Meeting
John M. Burke, MD
Peter Martin, MD
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: May 10, 2022
Expired:
May 9, 2023
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.